Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rebeck, G. W.
Right arrow Articles by Hyman, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rebeck, G. W.
Right arrow Articles by Hyman, B. T.
NEUROLOGY 1994;44:1513
© 1994 American Academy of Neurology

Reduced apolipoprotein {epsilon}4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals

G. W. Rebeck, PhD, T. T. Perls, MD, H. L. West, MPhil, P. Sodhi, BA, L. A. Lipsitz, MD and B. T. Hyman, MD, PhD

Department of Neurology (Drs. Rebeck and Hyman, and H.L. West and P. Sodhi), Massachusetts General Hospital, Boston, MA; and the Hebrew Rehabilitation Center for Aged (Drs. Perls and Lipsitz), Boston, MA.

Recent genetic studies show that the apolipoprotein E {epsilon}4 allele (ApoE- {epsilon}4) is a risk factor for Alzheimer's disease (AD). If ApoE- {epsilon}4 individuals develop AD as they get older, we would expect a decrease in ApoE- {epsilon}4 allele frequency with increasing age. We found a marked decline in ApoE- {epsilon}4 allele frequency with advancing age in both AD and cognitively normal controls (p < 0.003), although in all age groups the ApoE- {epsilon}4 allele was overrepresented (p < 0.0001). Nonetheless, a few cognitively normal nonagenarians were ApoE- {epsilon}4 positive. Thus, our data support two new conclusions: (1) the ApoE- {epsilon}4 associated risk for AD is age-dependent, probably due to censoring by the earlier development of AD in ApoE- {epsilon}4 individuals, and (2) despite the ApoE- {epsilon}4 associated risk for AD, it is possible to reach extreme old age with normal cognition.

Address correspondence and reprint requests to Dr. Bradley T. Hyman, Department of Neurology, Warren 407, Massachusetts General Hospital, Boston, MA 02114.

Supported by NIH grants AG05598, P50AG05134, AG08487, an NIA Teaching Nursing Home Award AG04390, and the Brookdale Foundation H.L.W. is a Howard Hughes Medical Student Research Fellow.

Received December 17, 1993. Accepted in final form February 7, 1994.




This article has been cited by other articles:


Home page
AJGPHome page
E. M. Fine, D. C. Delis, S. R. Wetter, M. W. Jacobson, A. J. Jak, C. R. McDonald, J. C. Braga, L. J. Thal, D. P. Salmon, and M. W. Bondi
Cognitive Discrepancies Versus APOE Genotype as Predictors of Cognitive Decline in Normal-Functioning Elderly Individuals: A Longitudinal Study
Am J Geriatr Psychiatry, May 1, 2008; 16(5): 366 - 374.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
G. S. Zubenko, W. N. Zubenko, B. S. Maher, and N. S. Wolf
Reduced Age-Related Cataracts Among Elderly Persons Who Reach Age 90 With Preserved Cognition: A Biomarker of Successful Aging?
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2007; 62(5): 500 - 506.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
G. S. Zubenko, H. B. Hughes III, W. N. Zubenko, and B. S. Maher
Genome Survey for Loci That Influence Successful Aging: Results at 10-cM Resolution
Am J Geriatr Psychiatry, March 1, 2007; 15(3): 184 - 193.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
T. Reed, D. Carmelli, T. S. Robinson, S. A. Rinehart, and C. J. Williams
More Favorable Midlife Cardiovascular Risk Factor Levels in Male Twins and Mortality After 25 Years of Follow-Up Is Related to Longevity of Their Parents
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2003; 58(4): M367 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
Y.-H. Choi, J.-H. Kim, D. K. Kim, J.-W. Kim, D.-K. Kim, M. S. Lee, C. H. Kim, and S. C. Park
Distributions of ACE and APOE Polymorphisms and Their Relations With Dementia Status in Korean Centenarians
J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2003; 58(3): M227 - 231.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
G. S. Zubenko, J. S. Stiffler, H. B. Hughes III, M. J. Fatigati, and W. N. Zubenko
Genome Survey for Loci That Influence Successful Aging: Sample Characterization, Method Validation, and Initial Results for the Y Chromosome
Am J Geriatr Psychiatry, October 1, 2002; 10(5): 619 - 630.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. R. Royall and J. C. de la Torre
Alzheimer Disease as a Vascular Disorder: Nosological Evidence * Response
Stroke, September 1, 2002; 33(9): 2147 - 2148.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. T. Perls, J. Wilmoth, R. Levenson, M. Drinkwater, M. Cohen, H. Bogan, E. Joyce, S. Brewster, L. Kunkel, and A. Puca
Life-long sustained mortality advantage of siblings of centenarians
PNAS, June 11, 2002; 99(12): 8442 - 8447.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Elbaz and A. Alperovitch
Bias in Association Studies Resulting from Gene-Environment Interactions and Competing Risks
Am. J. Epidemiol., February 1, 2002; 155(3): 265 - 272.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. H.S. Leung, W.S. Poon, L.M. Yu, G. K.C. Wong, and H.K. Ng
Apolipoprotein E Genotype and Outcome in Aneurysmal Subarachnoid Hemorrhage
Stroke, February 1, 2002; 33(2): 548 - 552.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. B Psychol. Sci. Soc. Sci.Home page
M. H. Silver, E. Jilinskaia, and T. T. Perls
Cognitive Functional Status of Age-Confirmed Centenarians in a Population-Based Study
J. Gerontol. B. Psychol. Sci. Soc. Sci., May 1, 2001; 56(3): P134 - P140.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
T. Perls
Guest Editorial: Genetic and Phenotypic Markers Among Centenarians
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2001; 56(2): 67M - 70.
[Full Text]


Home page
Am J EpidemiolHome page
Z. Guo, L. Fratiglioni, M. Viitanen, L. Lannfelt, H. Basun, J. Fastbom, and B. Winblad
Apolipoprotein E Genotypes and the Incidence of Alzheimer's Disease among Persons Aged 75 Years and Older: Variation by Use of Antihypertensive Medication?
Am. J. Epidemiol., February 1, 2001; 153(3): 225 - 231.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. C. Wang, J. M. Kwon, P. Shah, J. C. Morris, and A. Goate
Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease
Neurology, December 12, 2000; 55(11): 1644 - 1649.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Ganguli, V. Chandra, M. I. Kamboh, J. M. Johnston, H. H. Dodge, B. K. Thelma, R. C. Juyal, R. Pandav, S. H. Belle, and S. T. DeKosky
Apolipoprotein E Polymorphism and Alzheimer Disease: The Indo-US Cross-National Dementia Study
Arch Neurol, June 1, 2000; 57(6): 824 - 830.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. B Psychol. Sci. Soc. Sci.Home page
K. P. Riley, D. A. Snowdon, A. M. Saunders, A. D. Roses, J. A. Mortimer, and N. Nanayakkara
Cognitive Function and Apolipoprotein E in Very Old Adults: Findings From the Nun Study
J. Gerontol. B. Psychol. Sci. Soc. Sci., March 1, 2000; 55(2): 69S - 75.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
L. A. Farrer, T. Sherbatich, S. A. Keryanov, G. I. Korovaitseva, E. A. Rogaeva, S. Petruk, S. Premkumar, Y. Moliaka, Y. Q. Song, Y. Pei, et al.
Association Between Angiotensin-Converting Enzyme and Alzheimer Disease
Arch Neurol, February 1, 2000; 57(2): 210 - 214.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Juva, A. Verkkoniemi, P. Viramo, T. Polvikoski, K. Kainulainen, K. Kontula, and R. Sulkava
APOE {epsilon}4 does not predict mortality, cognitive decline, or dementia in the oldest old
Neurology, January 25, 2000; 54(2): 412 - 412.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G. B Frisoni, M. Manfredi, C. Geroldi, G. Binetti, O. Zanetti, A. Bianchetti, and M. Trabucchi
The prevalence of apoE-epsilon 4 in Alzheimer's disease is age dependent
J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 103 - 106.
[Abstract] [Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
I. Skoog, C. Hesse, O. Aevarsson, S. Landahl, J. Wahlström, P. Fredman, and K. Blennow
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality
J. Neurol. Neurosurg. Psychiatry, January 1, 1998; 64(1): 37 - 43.
[Abstract] [Full Text]


Home page
ScienceHome page
J. H. Morrison and P. R. Hof
Life and Death of Neurons in the Aging Brain
Science, October 17, 1997; 278(5337): 412 - 419.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. L. Biere, B. Ostaszewski, E. R. Stimson, B. T. Hyman, J. E. Maggio, and D. J. Selkoe
Amyloid beta -Peptide Is Transported on Lipoproteins and Albumin in Human Plasma
J. Biol. Chem., December 20, 1996; 271(51): 32916 - 32922.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Y. Itoh, M. Yamada, N. Suematsu, M. Matsushita, and E. Otomo
Influence of Apolipoprotein E Genotype on Cerebral Amyloid Angiopathy in the Elderly
Stroke, February 1, 1996; 27(2): 216 - 218.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. A. Puca, M. J. Daly, S. J. Brewster, T. C. Matise, J. Barrett, M. Shea-Drinkwater, S. Kang, E. Joyce, J. Nicoli, E. Benson, et al.
From the Cover: A genome-wide scan for linkage to human exceptional longevity identifies a locus on chromosome 4
PNAS, August 28, 2001; 98(18): 10505 - 10508.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by AAN Enterprises, Inc.